This compound is primarily utilized in the synthesis of pharmaceutical agents, particularly in the development of drugs targeting neurological disorders. It serves as a key intermediate in the production of compounds that modulate neurotransmitter systems, such as dopamine and serotonin receptors. Its trifluoromethyl group enhances the stability and bioavailability of the resulting drugs, making it valuable in medicinal chemistry. Additionally, it is explored in research for potential applications in treating anxiety, depression, and other central nervous system-related conditions. Its chiral nature allows for the creation of enantiomerically pure substances, which is crucial for optimizing therapeutic efficacy and reducing side effects.